Safety, Efficacy, and Tolerability of NBI-827104 for the Treatment of Essential Tremor

Status:
Recruiting

Trial end date:
2022-03-01

Target enrollment:

Participant gender:

The main objective of this study is to evaluate the efficacy, safety, and tolerability of NBI-827104 in adults with essential tremor.

Phase 2

Neurocrine Biosciences